Literature DB >> 26349067

Repeat peroral endoscopic myotomy: a salvage option for persistent/recurrent symptoms.

Quan-Lin Li1, Li-Qing Yao1, Xiao-Yue Xu1, Jun-Yu Zhu1, Mei-Dong Xu1, Yi-Qun Zhang1, Wei-Feng Chen1, Ping-Hong Zhou1.   

Abstract

BACKGROUND AND STUDY AIMS: Although peroral endoscopic myotomy (POEM) is credited with high success rates in the treatment of achalasia, persistent/recurrent symptoms may occasionally develop afterwards. Our purpose was to evaluate the feasibility, safety, and efficacy of repeat peroral endoscopic myotomy (Re-POEM) as salvage therapy after initial POEM failure. PATIENTS AND METHODS: Fifteen patients with persistence/recurrence of symptoms after previous POEM (Eckardt symptom score ≥ 4) were retrospectively selected from a prospectively maintained database housing a total of 1454 consecutive patients with achalasia. The primary endpoint was symptom relief during follow-up, defined by an Eckardt score of ≤ 3. Secondary outcome measures were procedure-related adverse events, change in manometric lower esophageal sphincter (LES) pressure, and reflux symptoms before and after Re-POEM.
RESULTS: All patients underwent successful Re-POEM a mean of 13.5 months (range 4 - 37 months) after execution of their primary POEM procedures. Mean operative time was 41.5 minutes (range 28 - 62 minutes). One instance of submucosal tunnel infection was successfully managed with conservative treatment. During a mean follow-up period of 11.3 months (range 3 - 18 months), therapeutic success was achieved in all patients. The mean symptom score pretreatment was 5.6 (range 4 - 8), compared with a post-treatment mean of 1.2 (range 0 - 3; P < 0.001). Mean LES pressure also declined from 25.0 mmHg to 9.5 mmHg after Re-POEM (P < 0.001). The overall clinical reflux complication rate of Re-POEM was 33.3 %.
CONCLUSIONS: Re-POEM appears safe and effective as a salvage option after initial POEM failure, conferring short-term symptom relief and being free of serious complications in all patients. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 26349067     DOI: 10.1055/s-0034-1393095

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  9 in total

1.  [Laparoscopic Heller myotomy after failed POEM and multiple balloon dilatations : Better late than never].

Authors:  L Giulini; A Dubecz; H J Stein
Journal:  Chirurg       Date:  2017-04       Impact factor: 0.955

2.  Outcome of peroral endoscopic myotomy in children with achalasia.

Authors:  Zaheer Nabi; Mohan Ramchandani; Radhika Chavan; Santosh Darisetty; Rakesh Kalapala; Upender Shava; Manu Tandan; Rama Kotla; D Nageshwar Reddy
Journal:  Surg Endosc       Date:  2019-01-22       Impact factor: 4.584

Review 3.  POEM in the Treatment of Esophageal Disorders.

Authors:  Nasim Parsa; Mouen A Khashab
Journal:  Curr Treat Options Gastroenterol       Date:  2018-03

4.  Same site submucosal tunneling for a repeat per oral endoscopic myotomy: A safe and feasible option.

Authors:  Antonios N Wehbeh; Parit Mekaroonkamol; Qiang Cai
Journal:  World J Gastrointest Endosc       Date:  2016-10-16

5.  Per-oral endoscopic myotomy for achalasia cardia: outcomes in over 400 consecutive patients.

Authors:  Zaheer Nabi; Mohan Ramchandani; Radhika Chavan; Rakesh Kalapala; Santosh Darisetty; Guduru Venkat Rao; Nageshwar Reddy
Journal:  Endosc Int Open       Date:  2017-05

Review 6.  Peroral endoscopic myotomy for esophageal motility disorders.

Authors:  Jie Feng; Raja Waqar Ali; Jin-Yong Hao; Gui-Xiang Kong; Li-Hong Yang; Xiao-Jun Huang
Journal:  Esophagus       Date:  2019-10-12       Impact factor: 4.230

7.  New endoscopic classification of esophageal mucosa in achalasia: A predictor for submucosal fibrosis.

Authors:  Xiuxue Feng; Enqiang Linghu; Ningli Chai; Hui Ding
Journal:  Saudi J Gastroenterol       Date:  2018 Mar-Apr       Impact factor: 2.485

8.  European guidelines on achalasia: United European Gastroenterology and European Society of Neurogastroenterology and Motility recommendations.

Authors:  R A B Oude Nijhuis; G Zaninotto; S Roman; G E Boeckxstaens; P Fockens; M W Langendam; A A Plumb; Ajpm Smout; E M Targarona; A S Trukhmanov; Blam Weusten; Albert J Bredenoord
Journal:  United European Gastroenterol J       Date:  2020-02       Impact factor: 4.623

9.  Per-oral endoscopic dual myotomy for the treatment of achalasia.

Authors:  Xianglei Yuan; Zhe Feng; Yanshi Zhao; Xianhui Zeng; Liansong Ye; Wei Liu; Bing Hu
Journal:  Esophagus       Date:  2021-07-17       Impact factor: 4.230

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.